… to reproducibly extract quantitative features from available … the potential to identify imaging
biomarkers that mitigate the … progress made in radiomics in neuro-oncology. In addition, we …

Diffuse glioma molecular profiling with arterial spin labeling and dynamic susceptibility contrast
perfusion MRI: A comparative Page 1 Neuro-Oncology Advances 6(1), vdae113, 2024 | …

… An equally important effort to define the hallmarks of glial tumors will also advance precision
neuro-oncology and inform patient-specific therapeutics. This review summarizes past …

… diffusion-weighted imaging, or amino acid PET are increasingly applied in neuro-oncology. …
of these complex multiparametric data, neuro-oncology could benefit from the application of …

… This study assessed the current imaging practices amongst UK neuro-oncology … in
neuro-oncology clinical trials [48], we suspected that real-world neuro-oncology follow-up imaging …

… Despite this, it is currently seldom used in neuro-oncology, leaving analytic tools … neuro-oncology
literature utilizing reference space. Methods: A systematic review of the neuro-oncology …

… Radiation Oncology and neuro-oncology, a number … neuro-oncology with emphasis on
Radiation Oncology and connected the existing and evolving approaches in molecular biomarker …

… approaches in diagnosis and therapy of neuro-oncology. Also, we have discussed the recent
AI trends and its beneficial aspect in the field of neuro-oncology in worldwide and India and …

Background. Distinguishing true tumor progression (TP) from treatment-induced abnormalities
(eg, pseudoprogression (PP) after radiotherapy) on conventional MRI scans remains …

… However, quantitative imaging biomarkers that use radiomics to help identify patients who
will benefit from bevacizumab treatment before initiation of therapy have been researched. …